No connection

Search Results

CCJ

NEUTRAL
$122.15 Live
Cameco Corporation · NYSE
Target $138.16 (+13.1%)
$43.74 52W Range $135.24

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 25, 2026
Market cap
$53.2B
P/E
123.38
ROE
8.9%
Profit margin
16.9%
Debt/Equity
0.15
Dividend yield
0.14%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
Cameco exhibits a stable financial health profile with a Piotroski F-Score of 4/9 and a very conservative debt-to-equity ratio of 0.15. However, the stock is trading at an extreme premium, with a current price of $122.15 far exceeding both the Graham Number ($16.05) and the growth-based Intrinsic Value ($29.20). While earnings growth is robust at 45.3%, revenue growth remains stagnant at 1.5%, suggesting the current valuation is driven by sector speculation rather than fundamental organic expansion. The combination of a bearish technical trend (10/100) and mediocre insider sentiment (40/100) suggests a high risk of a price correction despite bullish analyst targets.

Key Strengths

Very low leverage with a Debt/Equity ratio of 0.15
Strong liquidity position with a Current Ratio of 2.47
Significant year-over-year earnings growth of 45.30%
Dominant market position in the uranium sector
Strong analyst consensus with a target price of $138.16

Key Risks

Extreme valuation with a P/E ratio of 123.38
Severe disconnect between current price and intrinsic value ($29.20)
Stagnant revenue growth (1.50% YoY) relative to price appreciation
Bearish technical trend (10/100) indicating potential momentum reversal
Low insider sentiment (40/100) suggesting lack of internal confidence at current levels
AI Fair Value Estimate
Based on comprehensive analysis
$42.5
-65.2% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
52
Moderate
Value
15
Future
65
Past
90
Health
60
Dividend
30
AI Verdict
Speculative Premium
Key drivers: Extreme P/E expansion, Uranium sector tailwinds, Strong balance sheet, Poor technical momentum
Confidence
90%
Value
15/100

Ref P/E, PEG, Graham Number

Positives
No standout positives identified.
Watchpoints
  • P/E of 123.38 is unsustainable
  • Price/Book of 10.56 is very high
  • Trades at 7.6x its Graham Number
Future
65/100

Ref Growth rates

Positives
  • 45.3% Earnings growth
  • Strong analyst target prices
Watchpoints
  • Revenue growth is nearly flat at 1.5%
Past
90/100

Ref Historical trends

Positives
  • Massive 5Y return of 650.9%
  • Strong 1Y momentum of 178.8%
Watchpoints
No urgent risks highlighted.
Health
60/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Low Debt/Equity (0.15)
  • Healthy Current Ratio (2.47)
Watchpoints
  • Piotroski F-Score of 4/9 is only 'Stable', not 'Strong'
Dividend
30/100

Ref Yield, Payout

Positives
  • Low payout ratio (17.78%)
Watchpoints
  • Negligible yield of 0.14%

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$122.15
Analyst Target
$138.16
Upside/Downside
+13.1%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for CCJ and closest competitors.

Updated 2026-04-24
CCJ
Cameco Corporation
Primary
5Y
+650.9%
3Y
+370.8%
1Y
+178.8%
6M
+38.9%
1M
+12.0%
1W
+1.2%
FAN
Diamondback Energy, Inc.
Peer
5Y
+190.8%
3Y
+47.9%
1Y
+22.1%
6M
+34.9%
1M
+7.5%
1W
-2.5%
BKR
Baker Hughes Company
Peer
5Y
+215.2%
3Y
+116.8%
1Y
+37.9%
6M
+26.3%
1M
-6.6%
1W
-3.3%
KMI
Kinder Morgan, Inc.
Peer
5Y
+168.4%
3Y
+73.3%
1Y
+7.0%
6M
-0.2%
1M
+0.4%
1W
+3.3%
OXY
Occidental Petroleum Corporation
Peer
5Y
+142.7%
3Y
+0.7%
1Y
+29.5%
6M
+32.0%
1M
+15.5%
1W
+0.8%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
123.38
Forward P/E
63.44
PEG Ratio
1.92
P/B Ratio
10.56
P/S Ratio
15.28
EV/Revenue
15.22
EV/EBITDA
58.16
Market Cap
$53.2B

Profitability

Profit margins and return metrics

Profit Margin 16.93%
Operating Margin 13.63%
Gross Margin 36.28%
ROE 8.89%
ROA 3.59%

Growth

Revenue and earnings growth rates

Revenue Growth +1.5%
Earnings Growth +45.3%
Q/Q Revenue Growth +1.5%
Q/Q Earnings Growth +46.9%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.15
Low debt
Current Ratio
2.47
Strong
Quick Ratio
1.51
Excellent
Cash/Share
$2.79

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$1.2B
Gross Margin
22.7%
Op. Margin
17.0%
Net Margin
16.6%
Total Assets
$10.3B
Liabilities
$3.4B
Equity
$6.9B
Debt/Equity
0.49x
Operating CF
$0.7B
CapEx
$-0.1B
Free Cash Flow
$0.6B
FCF Yield
84%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-05
$N/A
2026-02-13
$0.5
+12.9% surprise
2025-11-05
$N/A
-100.0% surprise
2025-07-31
$0.71
+37.6% surprise

Energy Sector Comparison

Comparing CCJ against 68 companies in the Energy sector (4 bullish, 23 neutral, 41 bearish)
P/E Ratio
123.38
This Stock
vs
33.87
Sector Avg
+264.3% (Expensive)
Return on Equity (ROE)
8.89%
This Stock
vs
2.38%
Sector Avg
+272.8% (Excellent)
Profit Margin
16.93%
This Stock
vs
6.3%
Sector Avg
+169.0% (Superior)
Debt to Equity
0.15
This Stock
vs
1.52
Sector Avg
-90.3% (Less Debt)
Revenue Growth
1.5%
This Stock
vs
26.86%
Sector Avg
-94.4% (Slower)
Current Ratio
2.47
This Stock
vs
2.34
Sector Avg
+5.4% (Better)

Similar Companies

Peer comparison within the same industry

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
9 analysts
William Blair
2026-04-20
init
Outperform
GLJ Research
2026-02-18
reit
Buy Buy
RBC Capital
2026-02-17
Maintains
Outperform Outperform
RBC Capital
2025-11-13
Maintains
Outperform Outperform
UBS
2025-11-10
init
Neutral
RBC Capital
2025-10-31
Maintains
Outperform Outperform
Goldman Sachs
2025-10-29
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning CCJ from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile